Nephro-Urology Monthly

Published by: Kowsar

Monitoring of Cyclosporine A Blood Levels in Clinical Settings

Mariusz Niemczyk 1 , *
Author Information
1 Department of Immunology, Transplant Medicine and Internal Diseases, Medical University of Warsaw, Poland
Article information
  • Nephro-Urology Monthly: March 01, 2012, 4 (2); 493-494
  • Published Online: March 1, 2012
  • Article Type: Letter
  • Received: October 11, 2011
  • Revised: October 18, 2011
  • Accepted: October 26, 2011
  • DOI: 10.5812/numonthly.2701

To Cite: Niemczyk M. Monitoring of Cyclosporine A Blood Levels in Clinical Settings, Nephro-Urol Mon. 2012 ; 4(2):493-494. doi: 10.5812/numonthly.2701.

Copyright © 2012, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Beiraghdar F, Rostami Z, Einollahi B. Cyclosporine Through and 2 Hour Post Dose Monitoring and Its Contributing Factors Among Pediatric Kidney Recipients. Nephro-Urol Mon. 2011; 3(4): 296-300
  • 2. Yoshimura N, Okamoto M, Akioka K, Kaihara S. Optimization of the use of cyclosporine in renal transplantation. Transplant Proc. 2004; 36(2 Suppl): 181S-5S[DOI][PubMed]
  • 3. Dunn SP. Neoral monitoring 2 hours post-dose and the pediatric transplant patient. Pediatr Transplant. 2003; 7(1): 25-30[DOI][PubMed]
  • 4. Nashan B, Bock A, Bosmans JL, Budde K, Fijter H, Jaques B, et al. Use of Neoral C monitoring: a European consensus. Transpl Int. 2005; 18(7): 768-78[DOI][PubMed]
  • 5. Hmiel SP, Canter C, Shepherd R, Lassa-Claxton S, Nadler M. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients. Pediatr Transplant. 2007; 11(5): 524-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments